NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/21/2026
Back to search
Official data from USPTO
HERANOVA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
HERANOVA
ST13
US500000098831068Class
5, 10, 44
Filing
98831068
Registration
8357775
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
07/21/2026
Trademark type
Word
Nice classes
5, 10, 44
Filing date
10/31/2024
Registration date
07/21/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/21/2026
Last transaction
07/21/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/08/2025
First use in commerce
12/08/2025
Drawing code
4
Owner type
03
Owner location
Burlington, MA, US
Examiner
KING, LINDA M
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Heranova Lifesciences Inc.
Representatives
Y. Jae Kim Kim IP Law Group LLC
Technical classification
Nice Classes
Class 5Class 10Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medical diagnostic assays for testing for the presence of biomarkers in blood or bodily fluids for diagnosing gynecological diseasesnamely endometriosis; Medical diagnostic assays for testing for the presence of biomarkers in uterine tissue for determining a patient's personalized and optimal embryo implantation time and for determining a patient's personalized treatment planas well as the composition of microbiomeincluding presence of normal lactobacillus and targeted pathogenic bacteriaEscherichiaKlebsiellaEnterococcusStreptococcusMycoplasmaChlamydiaUreaplasmaNeisseriaStaphylococcusGardnerella; Medical diagnostic assays for testing for the presence of biomarkers in uterine and vaginal tissue for determining a patient's personalized treatment plan; for bacterialfungal and resistance markers for determining a personalized treatment plan; Medical diagnostic assays for testing for the presence of biomarkers in human biological material for diagnosing gynecological diseasesprimary ovarian insufficiency; Pharmaceuticalstherapeutic drugs for treating endometriosisinfertilitygynecological diseases and disorders
Class 10
Medical devicessurgical and nonsurgical devices for treating endometriosisinfertilitygynecological diseases and disorders.
Class 44
Providing medical information in the field of gynecology; medical information services in the gynecological field; medical testing services for diagnostic purposes in the field of gynecologytesting services for detecting endometritisa woman's personalized embryo implantation timeand/or Pelvic Inflammatory Disease and antibiotic resistance either post-partum or in cases of unexplained infertility; medical diagnostic services for gynecological diseases and disordersfor detecting endometriosis by identifying and analyzing biomarkers for diagnostic and/or treatment purposes; medical assessment serviceshealth assessment of a patient's remaining childbearing years based on patient-specific health information.
Publications
History of USPTO decisions and trademark events.
21 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/21/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/01/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/01/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/09/2026
IUAF
USE AMENDMENT FILED
03/02/2026
EISU
TEAS STATEMENT OF USE RECEIVED
03/02/2026
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/02/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/08/2025
PUBO
PUBLISHED FOR OPPOSITION
07/08/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/02/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/03/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/02/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/02/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/02/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/08/2025
GNRT
NON-FINAL ACTION E-MAILED
05/08/2025
CNRT
NON-FINAL ACTION WRITTEN
05/08/2025
DOCK
ASSIGNED TO EXAMINER
05/05/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/04/2025
NWAP
NEW APPLICATION ENTERED
10/31/2024
Continuous trademark protection
Get notified about every new filing that threatens HERANOVA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.